Status: current, Defined. Date: 31-Oct 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4206081000168119 | Lyzalon (pregabalin 225 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4206091000168116 | Lyzalon 225 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lyzalon 225 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Lyzalon 225 mg capsule | Is a | pregabalin 225 mg capsule | true | Inferred relationship | Some | ||
| Lyzalon 225 mg capsule | Is a | Lyzalon | true | Inferred relationship | Some | ||
| Lyzalon 225 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Lyzalon 225 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 559199883 | |
| Lyzalon 225 mg capsule | has intended active ingredient | pregabalin | true | Inferred relationship | Some | 559199882 | |
| Lyzalon 225 mg capsule | has Australian BoSS | pregabalin | true | Inferred relationship | Some | 559199882 |
Reference Sets
Victoria reportable Schedule 4 medications reference set
South Australia reportable Schedule 4 medications reference set
Queensland Health QScript Schedule 4 monitored medicines reference set
New South Wales Reportable Schedule 4 medications reference set
Northern Territory Reportable Schedule 4 medications reference set
ACT Reportable Schedule 4 medications reference set
Trade product unit of use reference set
FHIR